Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

34.40 -2.58 (-6.98%)
Streaming Delayed Price Updated: 3:01 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
47 48 Next >
News headline image
Why Is Hims & Hers Health (HIMS) Stock Rocketing Higher Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 24.8% in the afternoon session after the company announced the acquisition of Sigmund (marketed as Trybe Labs), which will allow it to... 
Via StockStory
Topics Artificial Intelligence
News headline image
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News ↗
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime. 
Via The Motley Fool
News headline image
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
What Is Driving Hims & Hers Stock Higher? ↗
The stock is up 140% this year already. 
Via The Motley Fool
News headline image
Assessing Hims & Hers Health: Insights From 7 Financial Analysts ↗
 
Via Benzinga
News headline image
Hims & Hers Health Unusual Options Activity For February 10 ↗
 
Via Benzinga
News headline image
Hims & Hers Health Stock Hits All-Time Highs: What's Going On? ↗
Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab testing. Positive analyst coverage may also be boosting the stock. Here's what... 
Via Benzinga
News headline image
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Earnings Could Be a Game Changer—What to Do Now
After a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick saved up before earnings announcements. 
Via MarketBeat
News headline image
3 Hot Stocks That Have Already Doubled in 2025 ↗
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year. 
Via The Motley Fool
News headline image
Hims & Hers Health Unusual Options Activity ↗
 
Via Benzinga
News headline image
Hims & Hers Stock Is On Fire, But Is It a Bubble? ↗
The stock isn't as expensive as you might think. 
Via The Motley Fool
News headline image
This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Hims & Hers: From Viral Ad to Volatile Stock
Hims & Hers leverages its viral Super Bowl advertisement and strategic weight loss market entry to achieve stock gains and brand recognition in telehealth. 
Via MarketBeat
News headline image
Hims & Hers Health Stock: A Millionaire-Maker in the Making? ↗
The stock has sprinted past $50 per share, after trading at $3 less than two years ago. 
Via The Motley Fool
News headline image
Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path ↗
A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking. 
Via Stocktwits
News headline image
Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
Novo Nordisk shares are closing in on a new 52-week low. Is the stock gearing up for a recovery with sentiment currently low? 
Via MarketBeat
News headline image
Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? ↗
In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB. 
Via Benzinga
News headline image
Stocks Brush Off Global Trade Tensions, PPI Data ↗
Stocks are firmly higher today, despite rising global trade tensions and another hotter-than-expected inflation reading. 
Via Talk Markets
Topics Economy Stocks / Equities World Trade
News headline image
Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Why Hims & Hers Terrifies Big Pharma ↗
Big pharma tried to stop Hims & Hers' Super Bowl ad. 
Via The Motley Fool
News headline image
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs. 
Via MarketBeat
News headline image
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today ↗
Via The Motley Fool
News headline image
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them ↗
The list of Super Bowl LIX commercials and the companies behind the Super Bowl ads. 
Via Benzinga
News headline image
Hims & Hers Takes Aim At Big Pharma In Controversial Super Bowl Ad — Retail Loves The Fight ↗
The commercial aired Sunday night on Fox and positioned obesity as "America's deadliest epidemic" while criticizing the $160 billion weight-loss industry and the broader healthcare system. 
Via Stocktwits
News headline image
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst ↗
U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports. 
Via Benzinga
Topics World Trade
News headline image
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad ↗
Shares rocketed on Friday, but the company might not be out of hot water yet. 
Via Investor's Business Daily
News headline image
EXCLUSIVE: Is Super Bowl $7M Ad Cost Worth It? 61% Say No, 18% Say They Looked Up Companies After Last Year's NFL Championship ↗
Benzinga readers pick whether a $7 million Super Bowl cost is worth it for companies and how likely they are to look up a company that may be new to them after the big game. 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.